High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy

Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.

Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,103 · see citing works

Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice

Lindahl, P., Johansson, B. R., Levéen, P., & Betsholtz, C. (1997) · Science · doi:10.1126/science.277.5323.242 · Cited by 2,226 · see citing works

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

Willett, C. G., Boucher, Y., di Tomaso, E., Duda, D. G., Munn, L. L., Tong, R. T., Chung, D. C., Sahani, D. V., Kalva, S. P., Kozin, S. V., et al. (2004) · Nature Medicine · doi:10.1038/nm988 · Cited by 1,966 · see citing works

The myofibroblast in wound healing and fibrocontractive diseases

Gabbiani, G. (2003) · The Journal of Pathology · doi:10.1002/path.1427 · Cited by 1,630 · see citing works

Transport of molecules in the tumor interstitium: a review.

Jain, R. K. (1987) · PubMed · Cited by 1,357 · see citing works

Angiopoietin-1 protects the adult vasculature against plasma leakage

Thurston, G., Rudge, J. S., Ioffe, E., Zhou, H., Ross, L. H., Croll, S. D., Glazer, N. L., Holash, J. A., McDonald, D. M., & Yancopoulos, G. D. (2000) · Nature Medicine · doi:10.1038/74725 · Cited by 1,284 · see citing works

Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors

Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., & Jain, R. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0074 · Cited by 1,189 · see citing works

Barriers to Drug Delivery in Solid Tumors

Jain, R. K. (1994) · Scientific American · doi:10.1038/scientificamerican0794-58 · Cited by 1,074 · see citing works

Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors

Morikawa, S., Bałuk, P., Kaidoh, T., Haskell, A., Jain, R. K., & McDonald, D. M. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64920-6 · Cited by 987 · see citing works

Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics

Padera, T. P., Kadambi, A., di Tomaso, E., Carreira, C. M., Brown, E. B., Boucher, Y., Choi, N. C., Mathisen, D. J., Wain, J. R., Mark, E. J., et al. (2002) · Science · doi:10.1126/science.1071420 · Cited by 964 · see citing works

Interstitial-lymphatic mechanisms in the control of extracellular fluid volume

Aukland, K., & Reed, R. K. (1993) · Physiological Reviews · doi:10.1152/physrev.1993.73.1.1 · Cited by 938 · see citing works

Transport of molecules across tumor vasculature

Jain, R. K. (1987) · Cancer and Metastasis Reviews · doi:10.1007/bf00047468 · Cited by 869 · see citing works

Cancer cells compress intratumour vessels

Padera, T. P., Stoll, B. R., Tooredman, J. B., Capen, D., Tomaso, E. D., & Jain, R. K. (2004) · Nature · doi:10.1038/427695a · Cited by 857 · see citing works

Delivery of molecular and cellular medicine to solid tumors

Jain, R. K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.011 · Cited by 775 · see citing works

Inhibition of Vascular Endothelial Growth Factor (VEGF) Signaling in Cancer Causes Loss of Endothelial Fenestrations, Regression of Tumor Vessels, and Appearance of Basement Membrane Ghosts

Inai, T., Mancuso, M. R., Hashizume, H., Baffert, F., Haskell, A., Bałuk, P., Hu‐Lowe, D. D., Shalinsky, D. R., Thurston, G., Yancopoulos, G. D., et al. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63273-7 · Cited by 759 · see citing works

Untitled work

(1990) · PubMed · Cited by 757 · see citing works

Molecular mechanisms of lymphangiogenesis in health and disease

Alitalo, K. K., & Carmeliet, P. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00051-x · Cited by 737 · see citing works

Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.

Lee, C. G., Heijn, M., di Tomaso, E., Griffon, G., Ancukiewicz, M., Koike, C., Park, K. R., Ferrara, N., Jain, R. K., Suit, H. D., et al. (2000) · PubMed · Cited by 674 · see citing works

Transport of macromolecules across microvascular walls: the two-pore theory

Rippe, B., & Haraldsson, B. S. (1994) · Physiological Reviews · doi:10.1152/physrev.1994.74.1.163 · Cited by 564 · see citing works

Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: implications for wound healing.

Montesano, R., & Orci, L. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.13.4894 · Cited by 560 · see citing works

Delivery of molecular and cellular medicine to solid tumors1PII of original article: S0169-409X(97)00027-6. The article was originally published in Advanced Drug Delivery Reviews 26 (1997) 71–90.1

Jain, R. K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00131-9 · Cited by 529 · see citing works

Abnormalities of Basement Membrane on Blood Vessels and Endothelial Sprouts in Tumors

Baluk, P., Morikawa, S., Haskell, A., Mancuso, M., & McDonald, D. M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63540-7 · Cited by 528 · see citing works

Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse.

Boucher, Y., & Jain, R. K. (1992) · PubMed · Cited by 510 · see citing works

Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors

Abramsson, A., Lindblom, P., & Betsholtz, C. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318549 · Cited by 479 · see citing works

Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors

Abramsson, A., Lindblom, P., & Betsholtz, C. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18549 · Cited by 478 · see citing works

Untitled work

(2000) · PubMed · Cited by 475 · see citing works

Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors.

Pietras, K., Östman, A., SJÖQUIST, M., Buchdunger, E., Reed, R. K., Heldin, C., & Rubin, K. (2001) · PubMed · Cited by 449 · see citing works

Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy.

Pietras, K., Rubin, K., Sjöblom, T., Buchdunger, E., Sjöquist, M., Heldin, C., & Östman, A. (2002) · PubMed · Cited by 432 · see citing works

Direct measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleaching.

Chary, S. R., & Jain, R. K. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.14.5385 · Cited by 412 · see citing works

The next frontier of molecular medicine: Delivery of therapeutics

Jain, R. K. (1998) · Nature Medicine · doi:10.1038/nm0698-655 · Cited by 411 · see citing works

Platelet-Derived Growth Factor-B Enhances Glioma Angiogenesis by Stimulating Vascular Endothelial Growth Factor Expression in Tumor Endothelia and by Promoting Pericyte Recruitment

Guo, P., Hu, B., Gu, W., Xu, L., Wang, D., Huang, H.-J. S., Cavenee, W. K., & Cheng, S. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63905-3 · Cited by 367 · see citing works

Untitled work

(1999) · PubMed · Cited by 348 · see citing works

Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11

Wildiers, H. P. M. W., Guetens, G., Boeck, G. D., Verbeken, E. K., Landuyt, B., Landuyt, W., de Bruijn, E. A., & van Oosterom, A. T. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601005 · Cited by 333 · see citing works

Membrane ruffling and chemotaxis transduced by the PDGF beta-receptor require the binding site for phosphatidylinositol 3' kinase.

Wennström, S., Siegbahn, A., Yokote, K., Arvidsson, A., Heldin, C., Mori, S., & Claesson, L. (1994) · PubMed · Cited by 305 · see citing works

Untitled work

(2000) · PubMed · Cited by 295 · see citing works

β1 Integrin-mediated collagen gel contraction is stimulated by PDGF

Gullberg, D., Tingström, A., Thuresson, A., Olsson, L., Terracio, L., Borg, T. K., & Rubin, K. (1990) · Experimental Cell Research · doi:10.1016/0014-4827(90)90305-t · Cited by 270 · see citing works

Untitled work

(2001) · PubMed · Cited by 257 · see citing works

Untitled work

(1992) · PubMed · Cited by 252 · see citing works

Collagenase increases the transcapillary pressure gradient and improves the uptake and distribution of monoclonal antibodies in human osteosarcoma xenografts

Eikenes, L., Bruland, Ø. S., Brekken, C., & Davies, C. D. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1472 · Cited by 251 · see citing works

Untitled work

(1992) · PubMed · Cited by 247 · see citing works

Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration

Curnis, F., Sacchi, A., & Corti, A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15223 · Cited by 238 · see citing works

Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration

Curnis, F., Sacchi, A., & Corti, A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215223 · Cited by 228 · see citing works

Platelet isoforms of platelet-derived growth factor stimulate fibroblasts to contract collagen matrices.

Clark, R. A. F., Folkvord, J. M., Hart, C. E., Murray, M. J., & McPherson, J. M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114227 · Cited by 221 · see citing works

Untitled work

(1991) · PubMed · Cited by 220 · see citing works

Platelet-Derived Growth Factor Production by B16 Melanoma Cells Leads to Increased Pericyte Abundance in Tumors and an Associated Increase in Tumor Growth Rate

Furuhashi, M., Sjöblom, T., Abramsson, A., Ellingsen, J., Micke, P., Li, H., Folestad, E. B., Eriksson, U., Heuchel, R. L., Betsholtz, C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1489 · Cited by 204 · see citing works

Enhancement of fluid filtration across tumor vessels: Implication for delivery of macromolecules

Netti, P. A., Hamberg, L. M., Babich, J. W., Kierstead, D., Graham, W. A., Hunter, G. J. S., Wolf, G. L., Fischman, A. J., Boucher, Y., & Jain, R. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3137 · Cited by 203 · see citing works

Interstitial fluid pressure in breast cancer, benign breast conditions, and breast parenchyma

Nathanson, S. D., & Nelson, L. (1994) · Annals of Surgical Oncology · doi:10.1007/bf03187139 · Cited by 197 · see citing works

The significance of the “tissue pressure” of normal testicular and of neoplastic (Brown‐Pearce carcinoma) tissue in the rabbit

Young, J. S., Llumsden, C. E., & Stalker, A. (1950) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700620303 · Cited by 191 · see citing works

Platelet-derived growth factor β receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3′ kinase signaling

Heuchel, R. L., Berg, A., Tallquist, M. D., Åhlén, K., Reed, R. K., Rubin, K., Claesson, L., Heldin, C., & Soriano, P. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11410 · Cited by 188 · see citing works

Interstitial hypertension in carcinoma of uterine cervix in patients: possible correlation with tumor oxygenation and radiation response.

Roh, H., Boucher, Y., Kalnicki, S., Buchsbaum, R., Bloomer, W. D., & Jain, R. K. (1991) · PubMed · Cited by 180 · see citing works

Analysis of Mural Cell Recruitment to Tumor Vessels

Abramsson, A., Berlin, O., Papayan, H., Paulin, D., Shani, M., & Betsholtz, C. (2002) · Circulation · doi:10.1161/hc0102.101437 · Cited by 178 · see citing works

Untitled work

(1993) · PubMed · Cited by 166 · see citing works

Establishment and transformation diminish the ability of fibroblasts to contract a native collagen gel.

Steinberg, B. M., Smith, K., Colozzo, M. T., & Pollack, R. (1980) · The Journal of Cell Biology · doi:10.1083/jcb.87.1.304 · Cited by 156 · see citing works

Enhanced expression of cyclooxygenase (COX)-2 in human skin epidermal cancer cells: Evidence for growth suppression by inhibiting COX-2 expression

Higashi, Y., Kanekura, T., & Kanzaki, T. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000601)86:5 · Cited by 155 · see citing works

New and active role of the interstitium in control of interstitial fluid pressure: potential therapeutic consequences

Wiig, H., Rubin, K., & Reed, R. K. (2003) · Acta Anaesthesiologica Scandinavica · doi:10.1034/j.1399-6576.2003.00050.x · Cited by 151 · see citing works

STI571 enhances the therapeutic index of epothilone B by a tumor-selective increase of drug uptake.

Pietras, K., Stumm, M., Hubert, M., Buchdunger, E., Rubin, K., Heldin, C., McSheehy, P. M. J., Wartmann, M., & Östman, A. (2003) · PubMed · Cited by 141 · see citing works

A novel physiological function for platelet‐derived growth factor‐BB in rat dermis.

Rodt, S. Å., Åhlén, K., Berg, A., Rubin, K., & Reed, R. K. (1996) · The Journal of Physiology · doi:10.1113/jphysiol.1996.sp021584 · Cited by 136 · see citing works

Blockade of beta 1-integrins in skin causes edema through lowering of interstitial fluid pressure.

Reed, R. K., Rubin, K., Wiig, H., & Rodt, S. Å. (1992) · Circulation Research · doi:10.1161/01.res.71.4.978 · Cited by 119 · see citing works

Lowering of tumor interstitial fluid pressure specifically augments efficacy of chemotherapy

Salnikov, A. V., Iversen, V. V., Koisti, M. J., Sundberg, C., Johansson, L. O. M., Stuhr, L. E. B., Sjöquist, M., Ahlström, H. K., Reed, R. K., & Rubin, K. (2003) · The FASEB Journal · doi:10.1096/fj.02-1201fje · Cited by 116 · see citing works

Reduction of interstitial fluid pressure after TNF-alpha treatment of three human melanoma xenografts

Kristensen, C. A., Nozue, M., Boucher, Y., & Jain, R. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.397 · Cited by 113 · see citing works

Nicotinamide can lower tumor interstitial fluid pressure: mechanistic and therapeutic implications.

Lee, I., Boucher, Y., & Jain, R. K. (1992) · PubMed · Cited by 105 · see citing works

Acute postburn edema: role of strongly negative interstitial fluid pressure

Lund, T., Wiig, H., & Reed, R. K. (1988) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1988.255.5.h1069 · Cited by 98 · see citing works

Macromolecular basis of globular protein exclusion and of swelling pressure in loose connective tissue (Umbilical cord)

Meyer, F. A. (1983) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(83)90242-8 · Cited by 95 · see citing works

Dexamethasone reduces the interstitial fluid pressure in a human colon adenocarcinoma xenograft.

Kristjansen, P. E. G., Boucher, Y., & Jain, R. K. (1993) · PubMed · Cited by 75 · see citing works

Lack of General Correlation between Interstitial Fluid Pressure and Oxygen Partial Pressure in Solid Tumors

Boucher, Y., Lee, I., & Jain, R. K. (1995) · Microvascular Research · doi:10.1006/mvre.1995.1051 · Cited by 62 · see citing works

Increasing tumor uptake of anticancer drugs with imatinib

Pietras, K. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.03.036 · Cited by 61 · see citing works

Control of interstitial fluid pressure: Role of [beta ]-integrins

Reed, R. K., Berg, A., Gjerde, E.-A. B., & Rubin, K. (2001) · Seminars in Nephrology · doi:10.1053/snep.2001.21646 · Cited by 61 · see citing works

Hyaluronidase reduces the interstitial fluid pressure in solid tumours in a non-linear concentration-dependent manner

Brekken, C., & Davies, C. D. L. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00202-x · Cited by 54 · see citing works

Interference with TGF‐β1 and ‐β3 in tumor stroma lowers tumor interstitial fluid pressure independently of growth in experimental carcinoma

Lammerts, E., Roswall, P., Sundberg, C., Gotwals, P. J., Koteliansky, V., Reed, R. K., Heldin, N., & Rubin, K. (2002) · International Journal of Cancer · doi:10.1002/ijc.10722 · Cited by 53 · see citing works

Acute postburn edema: Role of strongly negative interstitial fluid pressure

Lund, T., Wiig, H., & Reed, R. K. (1989) · Journal of Critical Care · doi:10.1016/0883-9441(89)90039-7 · Cited by 53 · see citing works

Hyaluronidase-induced periodic modulation of the interstitial fluid pressure increases selective antibody uptake in human osteosarcoma xenografts.

Brekken, C., Hjelstuen, M., Bruland, Ø. S., & Davies, C. D. L. (2000) · PubMed · Cited by 53 · see citing works

Characterization of Neuroblastoma Xenograft in Rat Flank. I. Growth, Interstitial Fluid Pressure, and Interstitial Fluid Velocity Distribution Profiles

DiResta, G. R., Lee, J., Larson, S. M., & Arbit, E. (1993) · Microvascular Research · doi:10.1006/mvre.1993.1044 · Cited by 51 · see citing works

Interstitial fluid pressure in human osteosarcoma xenografts: significance of implantation site and the response to intratumoral injection of hyaluronidase.

Brekken, C., Bruland, Ø. S., & Davies, C. D. L. (2001) · PubMed · Cited by 50 · see citing works

Effect of PGE1, PGI2, and PGF2αanalogs on collagen gel compaction in vitro and interstitial pressure in vivo

Berg, A., Ekwall, A. H., Rubin, K., Stjernschantz, J., & Reed, R. K. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.274.2.h663 · Cited by 49 · see citing works

Control of Ca2+ wave propagation in mouse pancreatic acinar cells

Pfeiffer, F., Sternfeld, L., Schmid, A., & Schulz, I. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.274.3.c663 · Cited by 47 · see citing works

Bradykinin Modulation of Tumor Vasculature: II. Activation of Nitric Oxide and Phospholipase A2/Prostaglandin Signaling Pathways Synergistically Modifies Vascular Physiology and Morphology to Enhance Delivery of Chemotherapeutic Agents to Tumors

Emerich, D. F., Dean, R. L., Snodgrass, P., Lafreniere, D., Agostino, M., Wiens, T., Xiong, H., Hasler, B. P., Marsh, J. P., Pink, M. M., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38780-4 · Cited by 42 · see citing works

Integrin αvβ3 mediates platelet-derived growth factor-BB-stimulated collagen gel contraction in cells expressing signaling deficient integrin α2β1

Grundström, G., Mosher, D. F., Sakai, T., & Rubin, K. (2003) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.07.010 · Cited by 31 · see citing works

Cytochalasin D induces edema formation and lowering of interstitial fluid pressure in rat dermis

Berg, A., Rubin, K., & Reed, R. K. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.1.h7 · Cited by 30 · see citing works

Hyaluronan content in experimental carcinoma is not correlated to interstitial fluid pressure

Jacobson, A., Salnikov, A. V., Lammerts, E., Roswall, P., Sundberg, C., Heldin, P., Rubin, K., & Heldin, N. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00872-6 · Cited by 12 · see citing works

Principles of nanoparticle design for overcoming biological barriers to drug delivery

Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002 · see citing works

Analysis of nanoparticle delivery to tumours

Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218 · see citing works

The biology and function of fibroblasts in cancer

Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366 · see citing works

Angiogenesis in life, disease and medicine

Carmeliet, P. (2005) · Nature · doi:10.1038/nature04478 · Cited by 3,494 · see citing works

To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery

Danhier, F., Féron, O., & Véronique Préat, A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,827 · see citing works

Drug penetration in solid tumours

Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805 · see citing works

Extracellular matrix structure

Theocharis, A. D., Skandalis, S. S., Gialeli, C., & Karamanos, N. K. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.001 · Cited by 2,598 · see citing works

Role of platelet-derived growth factors in physiology and medicinePreprint

Andræ, J., Gallini, R., & Betsholtz, C. (2008) · Genes & Development · doi:10.1101/gad.1653708 · Cited by 2,444 · see citing works

Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma

Provenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D., & Hingorani, S. R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.007 · Cited by 2,195 · see citing works

Engineered Nanoparticles for Drug Delivery in Cancer Therapy

Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164 · see citing works

Drug Resistance and the Solid Tumor Microenvironment

Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116 · see citing works

Macrophages and Therapeutic Resistance in Cancer

Ruffell, B., & Coussens, L. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.015 · Cited by 1,474 · see citing works

Targeting the TGFβ signalling pathway in disease

Akhurst, R. J., & Hata, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3810 · Cited by 1,466 · see citing works

Tumor angiogenesis and vascular normalization: alternative therapeutic targets

Viallard, C., & Larrivée, B. (2017) · Angiogenesis · doi:10.1007/s10456-017-9562-9 · Cited by 1,435 · see citing works

Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress

Lammers, T., Kiessling, F., Hennink, W. E., & Storm, G. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.063 · Cited by 1,324 · see citing works

To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?

Danhier, F. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.015 · Cited by 1,288 · see citing works

Challenges associated with penetration of nanoparticles across cell and tissue barriers: A review of current status and future prospects

Barua, S., & Mitragotri, S. (2014) · Nano Today · doi:10.1016/j.nantod.2014.04.008 · Cited by 1,270 · see citing works

Clinical and therapeutic relevance of cancer-associated fibroblasts

Chen, Y., McAndrews, K. M., & Kalluri, R. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00546-5 · Cited by 1,230 · see citing works

Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors

Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Girard, O. M., Hanahan, D., Mattrey, R. F., & Ruoslahti, E. I. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.013 · Cited by 1,140 · see citing works

Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer

Jacobetz, M. A., Chan, D. S., Neesse, A., Bapiro, T. E., Cook, N., Frese, K. K., Feig, C., Nakagawa, T., Caldwell, M. E., Zecchini, H. I., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-302529 · Cited by 1,120 · see citing works

Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions

Felfoul, O., Mohammadi, M., Taherkhani, S., de Lanauze, D., Xu, Y. Z., Loghin, D., Essa, S., Jančík, S., Houle, D., Lafleur, M., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.137 · Cited by 1,111 · see citing works

Targeting Strategies for Tissue-Specific Drug Delivery

Zhao, Z., Ukidve, A., Kim, J., & Mitragotri, S. (2020) · Cell · doi:10.1016/j.cell.2020.02.001 · Cited by 1,114 · see citing works

Integrin-mediated mechanotransduction

Sun, Z., Guo, S., & Fässler, R. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201609037 · Cited by 1,079 · see citing works

Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization

Sun, Q., Zhou, Z., Qiu, N., & Shen, Y. (2017) · Advanced Materials · doi:10.1002/adma.201606628 · Cited by 1,063 · see citing works

Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles

Ernsting, M. J., Murakami, M., Roy, A., & Li, S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.013 · Cited by 1,018 · see citing works

Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review

Hossen, S., Hossain, M. K., Basher, M. K., Mia, M. N. H., Rahman, M. T., & Uddin, M. J. (2019) · Journal of Advanced Research · doi:10.1016/j.jare.2018.06.005 · Cited by 998 · see citing works

TGFβ biology in cancer progression and immunotherapy

Derynck, R., Turley, S. J., & Akhurst, R. J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0403-1 · Cited by 944 · see citing works

Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment

Dai, Y., Xu, C., Sun, X., & Chen, X. S. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00592f · Cited by 931 · see citing works

Modelling cancer in microfluidic human organs-on-chips

Sontheimer-Phelps, A., Hassell, B. A., & Ingber, D. E. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-018-0104-6 · Cited by 906 · see citing works

Dynamic interplay between the collagen scaffold and tumor evolution

Egeblad, M., Rasch, M. G., & Weaver, V. M. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.08.015 · Cited by 898 · see citing works

Local drug delivery strategies for cancer treatment: Gels, nanoparticles, polymeric films, rods, and wafers

Wolinsky, J. B., Colson, Y. L., & Grinstaff, M. W. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.11.031 · Cited by 848 · see citing works

Targeting of drugs and nanoparticles to tumors

Ruoslahti, E. I., Bhatia, S. N., & Sailor, M. J. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.200910104 · Cited by 833 · see citing works

Functional and Biomimetic Materials for Engineering of the Three-Dimensional Cell Microenvironment

Huang, G., Li, F., Zhao, X., Ma, Y., Li, Y., Lin, M., Jin, G., Lu, T. J., Genin, G. M., & Xu, F. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00094 · Cited by 825 · see citing works

Enzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy

Zhou, Q., Shao, S., Wang, J., Xu, C., Xiang, J., Piao, Y., Zhou, Z., Yu, Q., Tang, J., Liu, X., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0485-z · Cited by 822 · see citing works

Microenvironmental regulation of therapeutic response in cancer

Klemm, F., & Joyce, J. A. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.11.006 · Cited by 769 · see citing works

Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers

Fang, J., Islam, W., & Maeda, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.005 · Cited by 757 · see citing works

Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come

Yingchoncharoen, P., Kalinowski, D. S., & Richardson, D. R. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012070 · Cited by 744 · see citing works

In search of definitions: Cancer‐associated fibroblasts and their markers

Nurmik, M., Ullmann, P., Rodriguez, F., Haan, S., & Letellier, E. (2020) · International Journal of Cancer · doi:10.1002/ijc.32193 · Cited by 739 · see citing works

Interstitial Fluid and Lymph Formation and Transport: Physiological Regulation and Roles in Inflammation and Cancer

Wiig, H., & Swartz, M. A. (2012) · Physiological Reviews · doi:10.1152/physrev.00037.2011 · Cited by 726 · see citing works

Conquering the Hypoxia Limitation for Photodynamic Therapy

Wan, Y., Fu, L., Li, C., Lin, J., & Huang, P. (2021) · Advanced Materials · doi:10.1002/adma.202103978 · Cited by 705 · see citing works

Mechanisms of Multidrug Resistance in Cancer

Gillet, J., & Gottesman, M. M. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-416-6_4 · Cited by 696 · see citing works

Nanogels: An overview of properties, biomedical applications and obstacles to clinical translation

Soni, K. S., Desale, S. S., & Bronich, T. K. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.11.009 · Cited by 700 · see citing works

Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency

Li, Z., Lai, X., Fu, S., Ren, L. F., Cai, H., Zhang, H., Gu, Z., Ma, X., & Luo, K. (2022) · Advanced Science · doi:10.1002/advs.202201734 · Cited by 688 · see citing works

The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment

Yang, M., Li, J., Gu, P., & Fan, X. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.12.010 · Cited by 680 · see citing works

Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets

Di, X., Gao, X., Peng, L., Ai, J., Jin, X., Qi, S., Li, H., Wang, K., & Luo, D. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01501-9 · Cited by 660 · see citing works

Targeting tumor‐associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake

Loeffler, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26532 · Cited by 633 · see citing works

Recent advances of cocktail chemotherapy by combination drug delivery systems

Hu, Q., Sun, W., Wang, C., & Gu, Z. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.022 · Cited by 625 · see citing works

Therapeutic targeting of the tumor microenvironment

Joyce, J. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.024 · Cited by 580 · see citing works

Vascular normalization in Rgs5-deficient tumours promotes immune destruction

Hamzah, J., Jugold, M., Kiessling, F. M., Rigby, P. J., Manzur, M., Marti, H. H., Rabie, T., Kaden, S., Gröne, H., Hämmerling, G. J., et al. (2008) · Nature · doi:10.1038/nature06868 · Cited by 565 · see citing works

Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages

Guerriero, J. L., Sotayo, A., Ponichtera, H. E., Castrillon, J. A., Pourzia, A. L., Schad, S., Johnson, S. F., Carrasco, R. D., Lazo, S., Bronson, R. T., et al. (2017) · Nature · doi:10.1038/nature21409 · Cited by 558 · see citing works

Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity

Swartz, M. A., & Lund, A. W. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3186 · Cited by 544 · see citing works

Targeting the PDGF signaling pathway in tumor treatment

Heldin, C. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-97 · Cited by 541 · see citing works

Improving drug delivery to solid tumors: Priming the tumor microenvironment

Khawar, I. A., Kim, J. H., & Kuh, H.-J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.018 · Cited by 533 · see citing works

Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery

Rubbia‐Brandt, L., Giostra, E., Brézault, C., Roth, A., Andrès, A., Audard, V., Sartoretti, P., Dousset, B. E., Majno, P. E., Soubrane, O., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl386 · Cited by 524 · see citing works

Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance

Khalaf, K., Hana, D., Chou, J. T.-T., Singh, C., Mackiewicz, A. A., & Kaczmarek, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.656364 · Cited by 526 · see citing works

Interstitial flow influences direction of tumor cell migration through competing mechanisms

Polacheck, W. J., Charest, J. L., & Kamm, R. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103581108 · Cited by 509 · see citing works

Rational combinations of targeted cancer therapies: background, advances and challenges

Jin, H., Wang, L., & Bernards, R. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00615-z · Cited by 503 · see citing works

Targeting the microenvironment in solid tumors

Belli, C., Trapani, D., Viale, G., D’Amico, P., Duso, B. A., Vigna, P. D., Orsi, F., & Curigliano, G. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.02.004 · Cited by 506 · see citing works

Senescent Human Fibroblasts Increase the Early Growth of Xenograft Tumors via Matrix Metalloproteinase Secretion

Liu, D., & Hornsby, P. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3452 · Cited by 499 · see citing works

TGF-β Signaling in Lung Health and Disease

Saito, A., Horie, M., & Nagase, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082460 · Cited by 501 · see citing works

Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology

Nissen, N. I., Karsdal, M. A., & Willumsen, N. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1110-6 · Cited by 492 · see citing works

VEGF and angiopoietin signaling in tumor angiogenesis and metastasis

Saharinen, P., Eklund, L., Pulkki, K. H., Bono, P., & Alitalo, K. K. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.01.015 · Cited by 478 · see citing works

Extracellularly Activated Nanocarriers: A New Paradigm of Tumor Targeted Drug Delivery

Gullotti, E., & Yeo, Y. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900090z · Cited by 471 · see citing works

Roles of p53, MYC and HIF-1 in regulating glycolysis–the seventh hallmark of cancer

Yeung, S. J., Pan, J., & Lee, M.-H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8224-x · Cited by 514 · see citing works

Biodistribution, Clearance, and Long‐Term Fate of Clinically Relevant Nanomaterials

Bourquin, J., Milosevic, A. M., Hauser, D., Lehner, R., Blank, F., Petri‐Fink, A., & Rothen‐Rutishauser, B. (2018) · Advanced Materials · doi:10.1002/adma.201704307 · Cited by 470 · see citing works

Tumor penetrating peptides for improved drug delivery

Ruoslahti, E. I. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.008 · Cited by 461 · see citing works

Phototherapy in cancer treatment: strategies and challenges

Cai, Y., Chai, T., Nguyen, W., Liu, J., Xiao, E., Ran, X., Ran, Y., Du, D., Chen, W., & Chen, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02140-y · Cited by 453 · see citing works

Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy

Niu, G., & Chen, X. S. (2010) · Current Drug Targets · doi:10.2174/138945010791591395 · Cited by 449 · see citing works

Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers

Zhao, Z., Ukidve, A., Krishnan, V., & Mitragotri, S. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.002 · Cited by 449 · see citing works

The tumor microenvironment is a dominant force in multidrug resistance

Correia, A. L., & Bissell, M. J. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.01.006 · Cited by 443 · see citing works

Bevacizumab-Induced Transient Remodeling of the Vasculature in Neuroblastoma Xenografts Results in Improved Delivery and Efficacy of Systemically Administered Chemotherapy

Dickson, P. V., Hamner, J. B., Sims, T. L., Fraga, C. H., Ng, C. Y., Rajasekeran, S., Hagedorn, N. L., McCarville, M. B., Stewart, C. F., & Davidoff, A. M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0278 · Cited by 443 · see citing works

The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternatives

Sun, R., Xiang, J., Zhou, Q., Piao, Y., Tang, J., Shao, S., Zhou, Z., Bae, Y. H., & Shen, Y. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114614 · Cited by 442 · see citing works

Chemophototherapy: An Emerging Treatment Option for Solid Tumors

Luo, D., Carter, K. A., Miranda, D., & Lovell, J. F. (2016) · Advanced Science · doi:10.1002/advs.201600106 · Cited by 436 · see citing works

Stimuli-Responsive Nano-Architecture Drug-Delivery Systems to Solid Tumor Micromilieu: Past, Present, and Future Perspectives

El‐Sawy, H. S., Al-Abd, A. M., Ahmed, T. A., El‐Say, K. M., & Torchilin, V. P. (2018) · ACS Nano · doi:10.1021/acsnano.8b06104 · Cited by 435 · see citing works

Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies

Tian, H., Zhang, T., Qin, S., Huang, Z., Zhou, L., Shi, J., Nice, E. C., Xie, N., Huang, C., & Shen, Z. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01320-5 · Cited by 443 · see citing works

Microfluidic cell culture systems for drug research

Wu, M.-H., Huang, S.-B., & Lee, G.-B. (2010) · Lab on a Chip · doi:10.1039/b921695b · Cited by 432 · see citing works

Cardiac fibroblasts: friend or foe?

Baudino, T. A., Carver, W., Giles, W., & Borg, T. K. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00023.2006 · Cited by 427 · see citing works

Peptides as Targeting Elements and Tissue Penetration Devices for Nanoparticles

Ruoslahti, E. I. (2012) · Advanced Materials · doi:10.1002/adma.201200454 · Cited by 418 · see citing works

Magnesium silicide nanoparticles as a deoxygenation agent for cancer starvation therapy

Zhang, C., Ni, D., Liu, Y., Yao, H., Bu, W., & Shi, J. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2016.280 · Cited by 413 · see citing works

Precise nanomedicine for intelligent therapy of cancer

Chen, H., Gu, Z., An, H., Chen, C., Chen, J., Cui, R., Chen, S., Chen, W., Chen, X., Chen, X. S., et al. (2018) · Science China Chemistry · doi:10.1007/s11426-018-9397-5 · Cited by 409 · see citing works

Biomaterials and emerging anticancer therapeutics: engineering the microenvironment

Gu, L., & Mooney, D. J. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2015.3 · Cited by 407 · see citing works

Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer

Watermann, A., & Brieger, J. (2017) · Nanomaterials · doi:10.3390/nano7070189 · Cited by 404 · see citing works

Anti-Inflammatory Drugs as Anticancer Agents

Zappavigna, S., Cossu, A. M., Grimaldi, A., Bocchetti, M., Ferraro, G. A., Nicoletti, G. F., Filosa, R., & Caraglia, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072605 · Cited by 401 · see citing works

Intraperitoneal Chemotherapy of Peritoneal Carcinomatosis Using Pressurized Aerosol as an Alternative to Liquid Solution: First Evidence for Efficacy

Solaß, W., Kerb, R., Mürdter, T. E., Giger-Pabst, U., Strumberg, D., Tempfer, C. M., Zieren, J., Schwab, M. G., & Reymond, M. A. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3213-1 · Cited by 386 · see citing works

Differentiation plasticity regulated by TGF-β family proteins in development and disease

Derynck, R., & Akhurst, R. J. (2007) · Nature Cell Biology · doi:10.1038/ncb434 · Cited by 411 · see citing works

Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics

Overchuk, M., & Zheng, G. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.10.024 · Cited by 383 · see citing works

Organ-on-a-chip platforms for studying drug delivery systems

Bhise, N. S., Ribas, J., Manoharan, V., Zhang, Y. S., Polini, A., Massa, S., Dokmeci, M. R., & Khademhosseini, A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.004 · Cited by 381 · see citing works

Challenges in Development of Targeted Liposomal Therapeutics

Sawant, R. R., & Torchilin, V. P. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9330-0 · Cited by 382 · see citing works

Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integration

Zhou, Z., Liu, X., Zhu, D., Wang, Y., Zhang, Z., Zhou, X., Qiu, N., Chen, X., & Shen, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.021 · Cited by 380 · see citing works

Immunologic tumor microenvironment modulators for turning cold tumors hot

Khosravi, G. R., Mostafavi, S., Bastan, S., Ebrahimi, N., Gharibvand, R. S., & Eskandari, N. (2024) · 癌症：英文版 · doi:10.1002/cac2.12539 · Cited by 384 · see citing works

Tissue stiffness, latent TGF-β1 Activation, and mechanical signal transduction: Implications for the pathogenesis and treatment of fibrosis

Hinz, B. (2009) · Current Rheumatology Reports · doi:10.1007/s11926-009-0017-1 · Cited by 373 · see citing works

Overcoming Physiologic Barriers to Cancer Treatment by Molecularly Targeting the Tumor Microenvironment

Cairns, R. A., Papandreou, I., & Denko, N. C. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0002 · Cited by 370 · see citing works

Rosmarinus officinalis L. (rosemary) as therapeutic and prophylactic agent

de Oliveira, J. R., Camargo, S. E. A., & de Oliveira, L. D. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0499-8 · Cited by 385 · see citing works

Polysaccharide‐Based Controlled Release Systems for Therapeutics Delivery and Tissue Engineering: From Bench to Bedside

Miao, T., Wang, J., Zeng, Y., Liu, G., & Chen, X. S. (2018) · Advanced Science · doi:10.1002/advs.201700513 · Cited by 369 · see citing works

Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro

Ng, C. P., Hinz, B., & Swartz, M. A. (2005) · Journal of Cell Science · doi:10.1242/jcs.02605 · Cited by 360 · see citing works

Engineered polymers for advanced drug delivery

Kim, S., Kim, J., Jeon, O., Kwon, I. C., & Park, K. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.021 · Cited by 355 · see citing works

Sonodynamic Therapy: Concept, Mechanism and Application to Cancer Treatment

McHale, A. P., Callan, J. F., Nomikou, N., Fowley, C., & Callan, B. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-22536-4_22 · Cited by 351 · see citing works

Antitumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma

Kakarla, S., Chow, K. K. H., Mata, M., Shaffer, D. R., Song, X., Wu, M.-F., Liu, H., Wang, L. L., Rowley, D. R., Pfizenmaier, K., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.110 · Cited by 347 · see citing works

The Use of Therapeutic Peptides to Target and to Kill Cancer Cells

Boohaker, R. J., Lee, M. W., Vishnubhotla, P., Perez, J. L. M., & Khaled, A. R. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712801661004 · Cited by 342 · see citing works

Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment

Chen, B., Dai, W., He, B., Zhang, H., Wang, X., Wang, Y., & Zhang, Q. (2017) · Theranostics · doi:10.7150/thno.16684 · Cited by 347 · see citing works

Targeting tumor interstitial fluid pressure: will it yield novel successful therapies for solid tumors?

Boeckelmann, L., & Schumacher, U. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1702974 · Cited by 76 · see citing works

Lowering of tumor interstitial fluid pressure specifically augments efficacy of chemotherapy

Salnikov, A. V., Iversen, V. V., Koisti, M. J., Sundberg, C., Johansson, L. O. M., Stuhr, L. E. B., Sjöquist, M., Ahlström, H. K., Reed, R. K., & Rubin, K. (2003) · The FASEB Journal · doi:10.1096/fj.02-1201fje · Cited by 116 · see citing works

Role of interstitial fluid pressure in tumor research

Li, A., & Xiu, R. (2008) · Guoji zhongliuxue zazhi · doi:10.3760/cma.j.issn.1673-422x.2008.09.004

Untitled work

(1990) · PubMed · Cited by 757 · see citing works

Modeling of interstitial fluid pressure in solid tumor

Pusenjak, J., & Damijan Miklavčič, A. (2000) · Simulation Practice and Theory · doi:10.1016/s0928-4869(00)00003-3 · Cited by 17 · see citing works